BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11434 related articles for article (PubMed ID: 10536987)

  • 1. Sulfur containing tyrosine analogs can cause selective melanocytotoxicity involving tyrosinase-mediated apoptosis.
    Minamitsuji Y; Toyofuku K; Sugiyama S; Yamada K; Jimbow K
    J Investig Dermatol Symp Proc; 1999 Sep; 4(2):130-6. PubMed ID: 10536987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
    Jimbow K
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs.
    Thomas PD; Kishi H; Cao H; Ota M; Yamashita T; Singh S; Jimbow K
    J Invest Dermatol; 1999 Dec; 113(6):928-34. PubMed ID: 10594732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy.
    Ito Y; Jimbow K
    Cancer Res; 1987 Jun; 47(12):3278-84. PubMed ID: 3107807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
    Gili A; Thomas PD; Ota M; Jimbow K
    Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-S-cysteaminylphenol and its analogues as substrates for tyrosinase and monoamine oxidase.
    Pankovich JM; Jimbow K; Ito S
    Pigment Cell Res; 1990 Sep; 3(3):146-9. PubMed ID: 2127097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model.
    Ishii-Osai Y; Yamashita T; Tamura Y; Sato N; Ito A; Honda H; Wakamatsu K; Ito S; Nakayama E; Okura M; Jimbow K
    J Dermatol Sci; 2012 Jul; 67(1):51-60. PubMed ID: 22622238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective cytotoxicity of N-acetyl-4-S-cysteaminylphenol on follicular melanocytes of black mice.
    Wong M; Jimbow K
    Br J Dermatol; 1991 Jan; 124(1):56-61. PubMed ID: 1993146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vivo melanocytotoxicity and depigmenting potency of N-2,4-acetoxyphenyl thioethyl acetamide in the skin and hair.
    Jimbow M; Marusyk H; Jimbow K
    Br J Dermatol; 1995 Oct; 133(4):526-36. PubMed ID: 7577578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydro-1,4-benzothiazine-6,7-dione, the ultimate toxic metabolite of 4-S-cysteaminylphenol and 4-S-cysteaminylcatechol.
    Hasegawa K; Ito S; Inoue S; Wakamatsu K; Ozeki H; Ishiguro I
    Biochem Pharmacol; 1997 May; 53(10):1435-44. PubMed ID: 9260870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes.
    Ito S; Kato T; Ishikawa K; Kasuga T; Jimbow K
    Biochem Pharmacol; 1987 Jun; 36(12):2007-11. PubMed ID: 3109434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo.
    Alena F; Jimbow K; Ito S
    Cancer Res; 1990 Jun; 50(12):3743-7. PubMed ID: 2340520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione plays a key role in the depigmenting and melanocytotoxic action of N-acetyl-4-S-cysteaminylphenol in black and yellow hair follicles.
    Alena F; Dixon W; Thomas P; Jimbow K
    J Invest Dermatol; 1995 May; 104(5):792-7. PubMed ID: 7738358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol.
    Prezioso JA; Wang N; Bloomer WD
    Cancer Chemother Pharmacol; 1992; 30(5):394-400. PubMed ID: 1505078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
    Miura T; Jimbow K; Ito S
    Int J Cancer; 1990 Nov; 46(5):931-4. PubMed ID: 2121652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytotoxicity of gamma-L-glutaminyl-4-hydroxybenzene for cells that contain tyrosinase, a study of melanocytes in the hair follicle of the mouse.
    Burger PC; Kemper LA; Vogel FS
    Cancer Res; 1979 May; 39(5):1494-503. PubMed ID: 106960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity.
    Yang F; Sarangarajan R; Le Poole IC; Medrano EE; Boissy RE
    J Invest Dermatol; 2000 Jan; 114(1):157-64. PubMed ID: 10620132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-propionyl-4-S-cysteaminylphenol.
    Tandon M; Thomas PD; Shokravi M; Singh S; Samra S; Chang D; Jimbow K
    Biochem Pharmacol; 1998 Jun; 55(12):2023-9. PubMed ID: 9714323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells.
    Prezioso JA; Epperly MW; Wang N; Bloomer WD
    Cancer Lett; 1992 Mar; 63(1):73-9. PubMed ID: 1555210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antimelanoma effects of 4-S-cysteaminylphenol and its homologues.
    Inoue S; Hasegawa K; Wakamatsu K; Ito S
    Melanoma Res; 1998 Apr; 8(2):105-12. PubMed ID: 9610862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 572.